Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials.

Sheehan, David V; Gasior, Maria; McElroy, Susan L; Radewonuk, Jana; Herman, Barry K; Hudson, James

Sheehan, David V; Gasior, Maria; McElroy, Susan L; Radewonuk, Jana; Herman, Barry K; Hudson, James.

Afiliación

Sheehan DV; Dr. Sheehan is with the University of South Florida College of Medicine in Tampa, Florida.
Gasior M; Drs. Herman and Gasior and Ms. Radewonuk are formerly affiliated with Shire Pharmaceuticals in Lexington, Massachusetts.
McElroy SL; Dr. McElroy is with the Lindner Center of HOPE and the University of Cincinnati College of Medicine in Mason, Ohio.
Radewonuk J; Dr. Hudson is with McLean Hospital/Harvard Medical School in Belmont, Massachusetts.
Herman BK; Dr. Sheehan is with the University of South Florida College of Medicine in Tampa, Florida.
Hudson J; Drs. Herman and Gasior and Ms. Radewonuk are formerly affiliated with Shire Pharmaceuticals in Lexington, Massachusetts.

Innov Clin Neurosci ; 15(5-6): 22-29, 2018 Jun 01.

Article en En | MEDLINE | ID: mdl-30013816

Palabras clave

Binge eating disorder; Sheehan Disability Scale; disability; functionality; lisdexamfetamine dimesylate

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Innov Clin Neurosci Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google